Breaking Boundaries, Precision Manufacturing: Huanqiu Medical Delivers Certainty in Balloon Manufacturing with "AI + Robotics"

The surge in market demand and the dramatic change in the policy environment are reshaping the competitive rules of China's interventional medical device industry.

On the one hand, the growing population of cardiovascular patients continues to drive up clinical demand. Data from Frost & Sullivan shows that the number of percutaneous coronary intervention (PCI) procedures in China is expected to reach approximately 3.438 million by 2030. On the other hand, under the "volume-based procurement" policy, vascular intervention balloons have gone through multiple rounds of bidding, with the average price reduction for some products still generally ranging between 50% and 89%.

This means that manufacturers must ensure the absolute reliability and consistent quality of their products while facing extreme price pressures. The traditional production model, which relies on manual labor and scale, has already hit its ceiling.

At this inflection point,Suzhou Huanqiu Medical Technology Co., Ltd.(Hereinafter referred to as "Huanqiu Medical") uses cross-border innovation as its edge, deeply integrating the precision manufacturing genes derived from the automotive industry with artificial intelligence and robotics. It not only provides intelligent equipment but also constructs a complete solution that reshapes the production logic, offering critical empowerment for the industrial upgrading of domestically produced interventional devices in China.

The starting point of Huanqiu Medical did not originate from within the medical industry, but rather from an apparently serendipitous cross-disciplinary conversation. At a gathering, the company's founder, Wenren Ji, spoke with a cardiac surgery expert about severe adverse events in some interventional treatments—events that ultimately required open-chest rescue procedures. During their review of the causes, the expert attributed the issues to three main sources: device design, the manufacturing process, and clinical operation.

"Millions of PCI surgeries are performed in China each year. Even a 0.001% probability of manufacturing defects, when multiplied by such a large base, represents specific patients and families." This set of figures led Wenren Ji, who has long been deeply involved in intelligent manufacturing in the automotive industry, to turn his attention to medical device production workshops for the first time.

After the investigation, a realistic problem surfaced: the manufacturing of interventional devices has long been in a state of "small batches, multiple varieties, and high dependence on manual labor," leading to poor product consistency, difficult quality traceability, and struggling under the dual pressures of cost and compliance.

This, however, stands in sharp contrast to the "high consistency, zero defects, and full-process data closed-loop" pursued by the automotive industry. A clear entrepreneurial logic thus emerges:Systematically transplant the mature precision manufacturing, robotics, and AI capabilities from the automotive industry into medical device manufacturing, using industrial-grade certainty to hedge against medical-grade risks.。

Crossing boundaries is no easy feat. To achieve this goal, Huanqiu Medical has built a "China-Germany Synergy" R&D and engineering system: The German team specializes in high-end precision manufacturing, is familiar with Europe's stringent compliance systems, and is responsible for cutting-edge technology validation and the development of some international markets; the Suzhou headquarters serves as the R&D and manufacturing center, ensuring technology implementation and rapid iteration; the Shanghai AI Software Center gathers local algorithm experts, focusing on overcoming core bottlenecks in intelligentization.

In terms of product pathway selection, Huanqiu Medical has not cast a wide net; instead, it has precisely locked onto the most technically challenging and quality-critical aspect of balloon manufacturing — the forming process.

Balloon forming is, in essence, a process extremely sensitive to thermodynamics. Minor temperature fluctuations can lead to uneven wall thickness, abnormal stress, and ultimately affect expansion performance and even clinical safety. The long-standing reality in the industry is that temperature control accuracy generally remains around ±10°C, with yield rates hovering between 70%–85%.

Huanqiu Medical chose to start from "the most difficult place." Through hundreds of process trials, Huanqiu Medical independently designed and iterated the water-jacket temperature control structure of the balloon-forming machine, improving the temperature control accuracy from the industry norm of ±10°C to ±2°C, enhancing production stability and the yield of high-quality balloons.

With this as the core, HuanQiu Medical started by addressing two key aspects—balloon stretching and testing—and gradually built up an intelligent product matrix covering the complete value chain of interventional device production.

● In the "Well-Made" section: Flagship ProductDual-mode Balloon Forming MachineIntegrated with multi-dimensional closed-loop control of temperature, tension, and air pressure, it can synchronously produce two balloon catheters within 130 seconds, supporting 200 customizable process recipes to flexibly respond to the demand for "small batches, multiple varieties."

Dual-Mode Balloon Forming Machine Model Schematic Diagram  Source: Huanqiu Medical

● In the "Accurate Testing" section：Balloon AI DetectorAndStent AI DetectorBuilt a quality defense line. By deeply integrating traditional visual precision imaging with AI intelligent interpretation, it reduces the missed detection rate by 90%, stably controlling it below 0.1%, and its performance surpasses that of an operator with two years of experience. Newly launchedVariable Diameter Screw AI Inspection Machine, with an accuracy of ±0.5μm, has solved the online detection problem for guidewires as thin as 0.01mm.

Schematic Diagram of Balloon AI Detector (Left) and Stent AI Detector (Right) Source: Huanqiu Medical

● In the "Liantong" section: Latest LaunchTube Pre-stretching MachineFilled the gap in the front-end process; all equipment passed"Huanqiu Quality Engine" (AI Quality Inspection Platform)Integrated with the factory MES system, aggregating full-process data to build a "digital twin" for production. This system not only enables full-process traceability but also predicts process drift and equipment anomalies through AI analysis, proactively providing optimization and maintenance recommendations. Meanwhile, specifically designed for medical cleanrooms.AMR (Autonomous Mobile Robot) Series, realizing the automated and intelligent flow of production materials in a strict environment.

Thus, Huanqiu Medical has formed a full-process data closed loop of "preprocessing - forming - welding - inspection - logistics," empowering the manufacturing end with traceability and optimizability intelligence.

The transformation brought by Huanqiu Medical goes far beyond the efficiency improvement within the factory. Its deeper value lies in,Linking Precision Control in Manufacturing to Clinical Safety and Efficacy at the Endpoint via Data Chains。

● Directly Reduce Clinical Risks：AI detection's precise interception of defects such as "uneven wall thickness" can effectively prevent the risk of balloon rupture within blood vessels; the forming machine’s extreme temperature consistency ensures stable balloon expansion performance, aiding in the precision of surgeries.

● Reconstructing Compliance and Traceability Systems: Full-process data recording enables second-level traceability for any product. Once there is clinical feedback, the problematic batch can be instantly locked, reducing quality investigations from "months" to "minutes," significantly lowering recall risks and costs for enterprises.

●Empower Supply Chain Resilience: The automated production line increases inspection efficiency by more than 100%, reducing the need for 3-5 quality control personnel per line. While cutting costs and improving efficiency, it ensures the stable and high-quality supply of critical devices such as balloons required for acute myocardial infarction surgeries.

"After the normalization of centralized procurement, what customers truly desire is not a breakthrough in a single parameter, but a manufacturing system that can consistently deliver certainty under extreme cost constraints," Wenren Ji summarized the industry changes.

Under this judgment, the original intention of the "Huanqiu Zhizhi" platform goes far beyond eliminating defective products. It focuses more on continuously modeling process parameters, defect characteristics, and equipment status to identify systemic fluctuations in advance, helping production remain within a predictable and reproducible stable range.

After the manufacturing capability was systematized, Huanqiu Medical's innovation further evolved into a business model. It launched"Modular Building Blocks" Solution, allowing customers to start with the most core molding and testing modules based on their own production capacity planning, and gradually build intelligent production lines like building blocks.

This provides a phased ROI (Return on Investment) realization pathway for numerous small and medium-sized medical device companies under pressure. Currently, Huanqiu Medical's solutions have entered the supply chains of several leading interventional device enterprises, gradually showing scale effects against the backdrop of accelerating China-produced alternatives.

Looking ahead, Suzhou Huanqiu Medical Technology Co., Ltd. has a clear strategy. In the next 3-5 years, the company's primary goal isPenetrate deeply into the core field of balloons, catheters, and guidewires, pursue the limits of craftsmanship, and establish a global intelligent manufacturing benchmark in this niche area.. On this basis, the verified "precision manufacturing + AI + data" technology platform will be prudently expanded into the broader high-value consumables field.

As Wenren Ji said: "The core of medical device intelligent manufacturing is to use industrial-grade precision and AI intelligence to safeguard medical-grade safety." In the transformation process of China-produced interventional devices from "catching up" to "running neck-and-neck" or even "taking the lead," the exploration and practice of Suzhou Huanqiu Medical Technology Co., Ltd. in the manufacturing sector may well be the key variable determining the industry's long-term competitiveness.